- Home
- EXEL vs MICC Comparison
EXEL vs MICC Comparison
Compare EXEL & MICC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | MICC |
|---|---|---|
| Founded | 1994 | 2025 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 12.1B |
| IPO Year | 2000 | 2025 |
Fundamental Metrics
Financial Performance| Metric | EXEL | MICC |
|---|---|---|
| Price | $70.52 | $20.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 4 |
| Target Price | ★ $59.79 | $19.40 |
| AVG Volume (30 Days) | ★ 2.3M | 848.1K |
| Earning Date | 10-29-2026 | 02-12-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $452,477,000.00 | N/A |
| Revenue This Year | $10.16 | $6.23 |
| Revenue Next Year | $12.43 | $4.13 |
| P/E Ratio | ★ $28.34 | $28.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.58 | $12.94 |
| 52 Week High | $72.10 | $20.69 |
Technical Indicators
Market Signals| Indicator | EXEL | MICC |
|---|---|---|
| Relative Strength Index (RSI) | 83.32 | 65.69 |
| Support Level | $54.85 | $18.83 |
| Resistance Level | N/A | $20.69 |
| Average True Range (ATR) | 1.80 | 0.34 |
| MACD | 0.59 | 0.19 |
| Stochastic Oscillator | 87.36 | 99.38 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About MICC The Magnum Ice Cream Company N.V. Ordinary Shares
The Magnum Ice Cream Company is a spinoff from Unilever, a pure-play company in manufacturing and selling a broad portfolio of ice-cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice-cream brands: the Heartbrand (an "umbrella" brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.